Roland Fiskesund1, Jun Su1, Ivana Bulatovic2, Max Vikström3, Ulf de Faire4, Johan Frostegård1. 1. Institute of Environmental Medicine, Unit of Immunology and Chronic Disease, Karolinska Institutet, Stockholm, Sweden. 2. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 3. Institute of Environmental Medicine, Division of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden. 4. Institute of Environmental Medicine, Division of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden ; Department of Cardiology, Karolinska University Hospital, Solna, Sweden.
Abstract
BACKGROUND: We have reported that anti-phosphorylcholine (anti-PC) IgM is a protection marker for human cardiovascular disease (CVD) and atherosclerosis. We here investigate the anti-PC autoantibodies in a well-defined cohort with regard to idiotype, atherosclerosis progression and mechanisms for its protective action. METHODS: Serum levels and binding specificities of different anti-PC isotypes were determined in 226 hypertensive individuals enrolled in European Lacidipine Study on Atherosclerosis using ELISA. The mean of the maximum Intima-Media Thicknesses (IMT) in the far walls of common carotids and bifurcations was assessed at the time of inclusion, and four years afterwards. Apoptosis in immune cells was induced with lysophosphatidylcholine (LPC) and quantified using the MTT-assay. RESULTS: Anti-PC IgM, IgA and IgG1 (but not IgG2) was negatively associated with IMT-progression. Combining anti-PC IgM with data on antibodies against oxidized- and malondialdehyde-modified LDL further strengthened this association. At very high levels, anti-PC IgM exhibited a striking negative association with atherosclerosis progression (OR 0.05; CI 0.006-0.40). Analysis of serum samples taken four years apart in study participants affirmed the stability of anti-PC IgM titers over time. Examination of fine specificities revealed that the protective isotypes (IgM, IgA and IgG1) are of the Group I idiotype whereas the non-protective IgG2 subclass was Group II. Anti-PC IgM inhibited LPC-induced cell death of immune cells. CONCLUSION: Group I anti-PC antibodies, particularly of the IgM class, are independent protection markers for atherosclerosis progression. One potential mechanism of action is inhibition of LPC-induced cell cytotoxicity.
BACKGROUND: We have reported that anti-phosphorylcholine (anti-PC) IgM is a protection marker for humancardiovascular disease (CVD) and atherosclerosis. We here investigate the anti-PC autoantibodies in a well-defined cohort with regard to idiotype, atherosclerosis progression and mechanisms for its protective action. METHODS: Serum levels and binding specificities of different anti-PC isotypes were determined in 226 hypertensive individuals enrolled in European Lacidipine Study on Atherosclerosis using ELISA. The mean of the maximum Intima-Media Thicknesses (IMT) in the far walls of common carotids and bifurcations was assessed at the time of inclusion, and four years afterwards. Apoptosis in immune cells was induced with lysophosphatidylcholine (LPC) and quantified using the MTT-assay. RESULTS: Anti-PC IgM, IgA and IgG1 (but not IgG2) was negatively associated with IMT-progression. Combining anti-PC IgM with data on antibodies against oxidized- and malondialdehyde-modified LDL further strengthened this association. At very high levels, anti-PC IgM exhibited a striking negative association with atherosclerosis progression (OR 0.05; CI 0.006-0.40). Analysis of serum samples taken four years apart in study participants affirmed the stability of anti-PC IgM titers over time. Examination of fine specificities revealed that the protective isotypes (IgM, IgA and IgG1) are of the Group I idiotype whereas the non-protective IgG2 subclass was Group II. Anti-PC IgM inhibited LPC-induced cell death of immune cells. CONCLUSION: Group I anti-PC antibodies, particularly of the IgM class, are independent protection markers for atherosclerosis progression. One potential mechanism of action is inhibition of LPC-induced cell cytotoxicity.
Entities:
Keywords:
Antibodies; Apoptosis; Biomarkers; Carotid intima media thickness; Phosphorylcholine
Authors: Jaewoo Choi; Wujuan Zhang; Xiaodong Gu; Xi Chen; Li Hong; James M Laird; Robert G Salomon Journal: Chem Res Toxicol Date: 2010-10-25 Impact factor: 3.739
Authors: Q S Mi; L Zhou; D H Schulze; R T Fischer; A Lustig; L J Rezanka; D M Donovan; D L Longo; J J Kenny Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205
Authors: Hans Grönlund; Göran Hallmans; Jan Håkan Jansson; Kurt Boman; Max Wikström; Ulf de Faire; Johan Frostegård Journal: Eur J Cardiovasc Prev Rehabil Date: 2009-06
Authors: Ulf de Faire; Jun Su; Xiang Hua; Anna Frostegård; Mats Halldin; Mai-Lis Hellenius; Max Wikström; Ingrid Dahlbom; Hans Grönlund; Johan Frostegård Journal: J Autoimmun Date: 2009-09-02 Impact factor: 7.094
Authors: Eva Cecilie Knudsen; Ingebjørg Seljeflot; Tonje Amb Aksnes; Jan Eritsland; Harald Arnesen; Geir Øystein Andersen Journal: PLoS One Date: 2019-04-19 Impact factor: 3.240